Expected Recovery Timeline Setting appropriate expectations for recovery timelines helps optimize protocol adherence and prevents premature disappointment or unnecessary protocol modifications
Contact For product documentation, batch information, or questions about these restrictions, contact [email protected]
Teva's FY2024 revenues of USD 16.5 billion (+7%) reflect the early stages of a commercial recovery from the financial restructuring of 20172022
The hCTR cells were cultured in growth medium consisting of Dulbeccos Modified Eagles Medium (DMEM, Gibco, #31966-021) supplemented with 10% v/v foetal bovine serum (FBS, Gibco, #16140-071), 1% v/v Penicillin-Streptomycin (Gibco, #15140-122), 0.6 mg/mL Geneticin G418 (Gibco, #10131-027) and 0.2 mg/mL Hygromycin (Invitrogen, #10687010)
Alkaline vs Acidic: Whats The Difference